Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CJ Europe is the European subsidiary of CJ CheilJedang, a South Korean conglomerate and a global leader in the biotechnology industry. The company primarily operates within the BIO business unit, focusing on the production and distribution of fermentation-derived products such as amino acids, nucleotides, and specialty ingredients. These products serve critical roles in the animal nutrition, human food, and pharmaceutical sectors across the EMEA region. In addition to its established market presence in bio-additives, CJ Europe is increasingly involved in the Red Bio space, facilitating the group's expansion into microbiome-based therapeutics and CDMO services for cell and gene therapies. Headquartered in Germany, the company provides comprehensive sales, marketing, and technical support to its diverse client base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CJ Europe.